PD-1 BLOCKADE AS AN ADJUNCT THERAPY FOR ART: IMPROVES ANTI-SIV IMMUNITY, VIROLOGIC RESPONSE TO ART AND GUT CD4 T-CELL RESTORATION

被引:0
|
作者
Velu, Vijayakumar [1 ]
Mylvaganam, Geetha [1 ]
Freeman, Gordon [2 ]
Ahmed, Rafi [1 ]
Amara, Rama [1 ]
机构
[1] Emory Univ, Sch Med, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA USA
[2] Harvard Univ, Sch Med, Boston, MA USA
关键词
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
35
引用
收藏
页码:393 / 393
页数:1
相关论文
共 50 条
  • [21] COEXPRESSION OF BTLA AND PD-1 IDENTIFIES A NOVEL CD4 T-CELL EXHAUSTION PHENOTYPE IN HUMAN HEPATOCELLULAR CARCINOMA
    Zhao, Q.
    Huang, Z. -L.
    Peng, L.
    Wang, P.
    Lin, C.
    Kuang, D. -M.
    Zheng, L.
    Gao, Z.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S576 - S576
  • [22] Intensification of suppressive ART with maraviroc reduces CD4 T-cell activation, increases early stage CD8 T cells and improves anti-HIV-1 function, without detriment to humoral recall response
    Westrop, S.
    Moyle, G.
    Nelson, M.
    Mandalia, S.
    Jackson, A.
    Gazzard, B.
    Imami, N.
    HIV MEDICINE, 2012, 13 : 9 - 10
  • [24] CD27 Agonism Plus PD-1 Blockade Recapitulates CD4+ T-cell Help in Therapeutic Anticancer Vaccination
    Ahrends, Tomasz
    Babala, Nikolina
    Xiao, Yanling
    Yagita, Hideo
    van Eenennaam, Hans
    Borst, Jannie
    CANCER RESEARCH, 2016, 76 (10) : 2921 - 2931
  • [25] Circulating Exhausted PD-1+CD39+ Helper CD4 T Cells Are Tumor-Antigen-Specific and Predict Response to PD-1/PD-L1 Axis Blockade
    Martinez-Gomez, Carlos
    Michelas, Marie
    Scarlata, Clara-Maria
    Salvioni, Anna
    Gomez-Roca, Carlos
    Sarradin, Victor
    Lauzeral-Vizcaino, Francoise
    Feliu, Virginie
    Dupret-Bories, Agnes
    Ferron, Gwenael
    Sarini, Jerome
    Devaud, Christel
    Delord, Jean-Pierre
    Balanca, Camille-Charlotte
    Martinez, Alejandra
    Ayyoub, Maha
    CANCERS, 2022, 14 (15)
  • [26] Expansion of Tumor-Infiltrating CD8+ T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell Therapy
    Fernandez-Poma, Sarita M.
    Salas-Benito, Diego
    Lozano, Teresa
    Casares, Noelia
    Riezu-Boj, Jose-Ignacio
    Mancheno, Uxua
    Elizalde, Edurne
    Alignani, Diego
    Zubeldia, Natalia
    Otano, Itziar
    Conde, Enrique
    Sarobe, Pablo
    Jose Lasarte, Juan
    Hervas-Stubbs, Sandra
    CANCER RESEARCH, 2017, 77 (13) : 3672 - 3684
  • [27] Blockade of CTLA-4 and PD-1 Enhances Adoptive T-cell Therapy Efficacy in an ICOS-Mediated Manner
    Shi, Lewis Zhichang
    Goswami, Sangeeta
    Fu, Tihui
    Guan, Baoxiang
    Chen, Jianfeng
    Xiong, Liangwen
    Zhang, Jan
    Tang, Derek Ng
    Zhang, Xuejun
    Vence, Luis
    Blando, Jorge
    Allison, James P.
    Collazo, Renata
    Gao, Jianjun
    Sharma, Padmanee
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (11) : 1803 - 1812
  • [28] PD-1 and PDL-1 expression in patients with chronic HIV-1 infection: relationship to CD4%, immune activation and antiretroviral therapy (ART)
    Sachdeva, Meenakshi
    Fischl, Margaret A.
    Pahwa, Savita
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [29] Combined blockade of the PD-1 and IL-10 pathways synergistically enhance HIV-specific CD4 T cell functions
    Porichis, F.
    Kwon, D. S.
    Tighe, D. P.
    Pavlik, D. F.
    Kavanagh, D. G.
    Freeman, G. J.
    Walker, B. D.
    Kaufmann, D. E.
    RETROVIROLOGY, 2009, 6
  • [30] Integrin-αV-mediated activation of TGF-β regulates anti-tumour CD8 T cell immunity and response to PD-1 blockade
    Malenica, Ines
    Adam, Julien
    Corgnac, Stephanie
    Mezquita, Laura
    Auclin, Edouard
    Damei, Isabelle
    Grynszpan, Laetitia
    Gros, Gwendoline
    de Montpreville, Vincent
    Planchard, David
    Theret, Nathalie
    Besse, Benjamin
    Mami-Chouaib, Fathia
    NATURE COMMUNICATIONS, 2021, 12 (01)